Cargando…

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review

BACKGROUND: Asthma is the most common chronic condition of childhood. Leukotriene receptor antagonists (LTRAs) are included in international guidelines for children and young people (CYP), but there have been highly publicised concerns about potential adverse effects. The aim was to identify and und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, Eleanor Grace, Rugg-Gunn, Charlotte EM, Sellick, Vanessa, Sinha, Ian P, Hawcutt, Daniel B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515462/ https://www.ncbi.nlm.nih.gov/pubmed/34712847 http://dx.doi.org/10.1136/bmjpo-2021-001206

Ejemplares similares

Deprescribing montelukast in children with asthma: a systematic review
por: Dixon, Eleanor Grace, et al.
Publicado: (2022)

Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
por: Rugg-Gunn, Charlotte EM, et al.
Publicado: (2021)

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators
por: Dahlke, Philipp, et al.
Publicado: (2023)

Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies
por: Thompson, Miles D., et al.
Publicado: (2016)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010)

Leukotriene Antagonists in Dermatology
por: Bubna, Aditya Kumar
Publicado: (2021)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Pharmacogenomics of Prostaglandin and Leukotriene Receptors
por: Cornejo-García, José A., et al.
Publicado: (2016)

Leukotrienes in Tumor-Associated Inflammation
por: Tian, Wen, et al.
Publicado: (2020)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope
por: Wang, Zhengying, et al.
Publicado: (2023)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
por: Ogawa, Norifumi, et al.
Publicado: (2012)

The effect of montelukast, a leukotriene receptor antagonist, on the acetic acid-induced model of colitis in rats: Involvement of NO-cGMP-K(ATP) channels pathway
por: Ghorbanzadeh, Behnam, et al.
Publicado: (2022)

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
por: King, Charlotte, et al.
Publicado: (2020)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Pharmacists’ experiences on adverse drug reaction: 10 years later
por: Karuppannan, Mahmathi, et al.
Publicado: (2022)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Valovirta, Erkka
Publicado: (2012)

Prospective identification and causality evaluation of suspected adverse drug reactions in neonates
por: Roberts, Eve K., et al.
Publicado: (2020)

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization
por: King, Charlotte, et al.
Publicado: (2020)

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
por: El-Khateeb, Eman, et al.
Publicado: (2023)

Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
por: Rosli, Rosliana, et al.
Publicado: (2017)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2021)

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
por: Shen, Shan, et al.
Publicado: (2022)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

Aminophylline Dosage In Asthma Exacerbations in Children: A Systematic Review
por: Cooney, Lewis, et al.
Publicado: (2016)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015)

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database
por: Magro, Lara, et al.
Publicado: (2021)

Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020
por: Jiang, Huaqiao, et al.
Publicado: (2022)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
por: Elzagallaai, Abdelbaset A., et al.
Publicado: (2021)

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
por: Funk, Colin D., et al.
Publicado: (2020)

Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)()
por: Bian, Sainan, et al.
Publicado: (2021)

Churg-Strauss syndrome associated with leukotriene receptor antagonists.
por: McAuley, D. F., et al.
Publicado: (2001)

Side effects of the leukotriene receptor antagonists in asthmatic children
por: Can, Demet, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ttbq8cvf87cct6o6b324tupdrf